10-K Filing

IOVANCE BIOTHERAPEUTICS, INC. CIK: 1425205 FY 2014

Filing Information

Form Type	10-K
Accession Number	`0001144204-15-016315`
Period End Date	20141231
Filing Date	20150316
Fiscal Year	2014
Fiscal Period	FY
XBRL Instance	lbio-20141231.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 59 Income Statement 29 Cash Flow Statement 57 Stockholders Equity 26

Balance Sheet 59 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$16.00K	USD	Point-in-time
Property and equipment, accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$104.22K	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Par or Stated Value Per Share (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	50.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	5,694.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	17,000.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$173.72K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$66.13K	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	5,694.00	shares	Point-in-time
Total Current Assets	`AssetsCurrent`	$44.98M	USD	Point-in-time
Total Current Assets	`AssetsCurrent`	$19.85M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	17,000.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $104,223 and $16,002	`PropertyPlantAndEquipmentNet`	$1.53M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $104,223 and $16,002	`PropertyPlantAndEquipmentNet`	$27.76K	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Common Stock, Par or Stated Value Per Share (in dollars per share)	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Total Assets	`Assets`	$46.51M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Total Assets	`Assets`	$19.87M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	33.75M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	20.02M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	33.75M	shares	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	20.02M	shares	Point-in-time
Common Stock To Be Issued Shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$412.98K	USD	Point-in-time
Common Stock To Be Issued Shares	`CommonStockToBeIssuedShares`	303,125.00	shares	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$1.52M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$327.85K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$85.50K	USD	Point-in-time
Accrued payable to officers and former directors	`AccountsPayableRelatedPartiesCurrent`	$338.73K	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$1.66M	USD	Point-in-time
Total Current Liabilities	`LiabilitiesCurrent`	$2.27M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 5,694 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$6.00	USD	Point-in-time
Preferred stock, $0.001 par value; 50,000,000 shares authorized, 5,694 shares and 17,000 shares issued and outstanding, respectively	`PreferredStockValue`	$17.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 33,750,188 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$835.00	USD	Point-in-time
Common stock, $0.000041666 par value; 150,000,000 shares authorized, 33,750,188 and 20,023,958 shares issued and outstanding, respectively	`CommonStockValue`	$1.41K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Common stock to be issued, 303,125 shares	`CommonStockToBeIssuedValue`	$245.15K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$121.16M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$81.88M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-76.56M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-64.53M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$44.85M	USD	Point-in-time
Total Stockholders' Equity	`StockholdersEquity`	$17.60M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$46.51M	USD	Point-in-time
Total Liabilities and Stockholders' Equity	`LiabilitiesAndStockholdersEquity`	$19.87M	USD	Point-in-time

Income Statement 29 line items

Line Item	Tag	Value	Unit	Period
Revenues	`Revenues`	-	USD	Annual
Revenues	`Revenues`	-	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$3.81M	USD	Annual
Share-based Compensation	`ShareBasedCompensation`	$2.75M	USD	Annual
Operating expenses (including $3,813,831 and $2,750,223 in share based compensation costs)	`OperatingCostsAndExpenses`	$9.34M	USD	Annual
Operating expenses (including $3,813,831 and $2,750,223 in share based compensation costs)	`OperatingCostsAndExpenses`	$4.66M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$1.33M	USD	Annual
Research and development	`ResearchAndDevelopmentExpense`	$2.70M	USD	Annual
Cost of Lion transaction	`NoncashMergerRelatedCosts`	-	USD	Annual
Cost of Lion transaction	`NoncashMergerRelatedCosts`	$16.66M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$22.64M	USD	Annual
Total costs and expenses	`OperatingExpenses`	$12.04M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-12.04M	USD	Annual
Loss from operations	`OperatingIncomeLoss`	$-22.64M	USD	Annual
Interest (expense) income	`InterestExpense`	$444.73K	USD	Annual
Interest (expense) income	`InterestExpense`	$-5.66K	USD	Annual
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	$2.30M	USD	Annual
Cost to induce exchange transaction	`CostToInduceExchangeTransaction`	-	USD	Annual
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$-2.74M	USD	Annual
Total other (expense) income	`OtherNonoperatingIncomeExpense`	$5.66K	USD	Annual
Net Loss	`NetIncomeLoss`	$-12.03M	USD	Annual
Net Loss	`NetIncomeLoss`	$-25.38M	USD	Annual
Deemed dividend related to beneficial conversion feature of convertible preferred stock	`OtherPreferredStockDividendsAndAdjustments`	$8.46M	USD	Annual
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-33.84M	USD	Annual
Net Loss Attributable to Common Stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-12.03M	USD	Annual
Net Loss Per Share, Basic and Diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-3.47	USD	Annual
Net Loss Per Share, Basic and Diluted (in dollars per share)	`EarningsPerShareBasicAndDiluted`	$-0.48	USD	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	9.76M	shares	Annual
Weighted-Average Common Shares Outstanding, Basic and Diluted (in shares)	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	24.99M	shares	Annual

Cash Flow Statement 57 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-12.03M	USD	Annual
Net loss	`NetIncomeLoss`	$-25.38M	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$7.09K	USD	Annual
Depreciation and amortization	`DepreciationAndAmortization`	$88.22K	USD	Annual
Fair value of vested stock options	`StockOptionPlanExpense`	$747.24K	USD	Annual
Fair value of vested stock options	`StockOptionPlanExpense`	$2.56M	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$1.26M	USD	Annual
Common stock issued for services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$274.00K	USD	Annual
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	$122.73K	USD	Annual
Common stock issued to induce conversion of warrants	`CommonStockIssuedToInduceConversionOfWarrants`	-	USD	Annual
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	-	USD	Annual
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	Annual
Common stock issued for Lion transaction	`NoncashMergerRelatedCosts`	-	USD	Annual
Common stock issued for Lion transaction	`NoncashMergerRelatedCosts`	$16.66M	USD	Annual
Common stock issued to directors	`StockIssued1`	-	USD	Annual
Common stock issued to directors	`StockIssued1`	$-2.00M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$166.44K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-107.58K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-587.21K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$-354.94K	USD	Annual
Accounts payable to officers and former directors	`IncreaseDecreaseInAccountsPayableRelatedParties`	$-253.23K	USD	Annual
Accounts payable to officers and former directors	`IncreaseDecreaseInAccountsPayableRelatedParties`	$43.65K	USD	Annual
Accrued interest and penalty	`IncreaseDecreaseInOtherAccruedLiabilities`	$445.74K	USD	Annual
Accrued interest and penalty	`IncreaseDecreaseInOtherAccruedLiabilities`	-	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-8.63M	USD	Annual
Net Cash Used In Operating Activities	`NetCashProvidedByUsedInOperatingActivitiesContinuingOperations`	$-3.66M	USD	Annual
Purchases of property and computer equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$12.71K	USD	Annual
Purchases of property and computer equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.59M	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-1.59M	USD	Annual
Net Cash Used In Investing Activities	`NetCashProvidedByUsedInInvestingActivitiesContinuingOperations`	$-12.71K	USD	Annual
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	-	USD	Annual
Proceeds from the issuance of common stock upon exercise of warrants	`ProceedsFromWarrantExercises`	$3.22M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$32.24M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$1.35M	USD	Point-in-time
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$7.13M	USD	Annual
Proceeds from the issuance of common stock, net	`ProceedsFromIssuanceOfCommonStock`	$32.24M	USD	Point-in-time
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	$311.50K	USD	Annual
Proceeds from the issuance of convertible notes, net	`ProceedsFromConvertibleDebt`	-	USD	Annual
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	$15.91M	USD	Annual
Proceeds from the issuance of preferred stock, net	`ProceedsFromIssuanceOfPreferredStockAndPreferenceStock`	-	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$35.46M	USD	Annual
Net Cash Provided By Financing Activities	`NetCashProvidedByUsedInFinancingActivitiesContinuingOperations`	$23.35M	USD	Annual
Net Increase In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$25.24M	USD	Annual
Net Increase In Cash And Cash Equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$19.67M	USD	Annual
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, Beginning of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$44.91M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	$19.67M	USD	Point-in-time
Cash and Cash Equivalents, End of Period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	-	USD	Annual
Common stock issued upon conversion of convertible notes	`DebtConversionOriginalDebtAmount1`	$6.79M	USD	Annual
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	-	USD	Annual
Settlement of accounts payable through issuance of common stock	`SettlementOfAccountsPayableThroughIssuanceOfCommonStock`	$25.00K	USD	Annual
Common stock issued upon conversion of accrued interest and penalty	`DebtConversionConvertedInstrumentAmount1`	$9.27M	USD	Point-in-time
Common stock issued upon conversion of accrued interest and penalty	`DebtConversionConvertedInstrumentAmount1`	$2.47M	USD	Annual
Common stock issued upon conversion of accrued interest and penalty	`DebtConversionConvertedInstrumentAmount1`	-	USD	Annual

Stockholders Equity 26 line items

Line Item	Tag	Value	Unit	Period
Balance at January 1,2013	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Balance at January 1,2013	`StockholdersEquity`	$44.85M	USD	Point-in-time
Balance at January 1,2013	`StockholdersEquity`	$17.60M	USD	Point-in-time
Common stock issued upon conversion of accrued interest and penalty	`StockIssuedDuringPeriodValueForSettlementOfNotesPayableAndAccruedLiabilities`	$9.27M	USD	Annual
Common stock issued for cash under the restructuring, net of offering costs of $109,990	`StockIssuedDuringPeriodValueIssuedForCash`	$1.24M	USD	Annual
Fair value of common stock issued for cancellation of outstanding warrants	`StockIssuedDuringPeriodValueIssuedForNoncashConsiderations`	$122.73K	USD	Annual
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalMarkToMarket`	$747.24K	USD	Annual
Fair value of vested stock options	`AdjustmentsToAdditionalPaidInCapitalMarkToMarket`	$2.56M	USD	Annual
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	-	USD	Annual
Common stock issued to induce exchange transaction	`CommonStockIssuedToInduceExchangeTransaction`	$2.17M	USD	Annual
Common stock issued for Lion transaction	`StockIssuedDuringPeriodValueAcquisitions`	$16.66M	USD	Annual
Common stock issued to directors	`StockIssuedDuringPeriodValueToDirectors`	$2.00M	USD	Annual
Common stock sold in private placement	`StockIssuedDuringPeriodValueOther`	$32.24M	USD	Annual
Common stock sold in private placement	`StockIssuedDuringPeriodValueOther`	$5.89M	USD	Annual
Preferred stock sold in private placement at $2.00 per share, November 2013, net of offering costs of $1,091,240	`PreferredStockSoldInPrivatePlacementValue`	$15.91M	USD	Annual
Common stock issued for settlement of payable	`StockIssuedDuringPeriodSharesForSettlementOfPayable`	$25.00K	USD	Annual
Deemed dividend on beneficial conversion feature of preferred stock	`AdjustmentsToAdditionalPaidInCapitalOther`	-	USD	Annual
Net loss	`ProfitLoss`	$-25.38M	USD	Annual
Net loss	`ProfitLoss`	$-12.03M	USD	Annual
Common stock issued upon exercise of warrants	`CommonStockIssuedUponExerciseOfWarrantsAmount`	$3.22M	USD	Annual
Common stock issued upon conversion of preferred shares	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$1.26M	USD	Annual
Common stock issued for services	`StockIssuedDuringPeriodValueIssuedForServices`	$274.00K	USD	Annual
Balance	`StockholdersEquity`	$-11.32M	USD	Point-in-time
Balance	`StockholdersEquity`	$44.85M	USD	Point-in-time
Balance	`StockholdersEquity`	$17.60M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.